Vitamin K3 attenuates STING-agonist-induced signaling and imiquimod-induced psoriasis-like inflammation
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2026.118477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Zuyi Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, Sch…. Hauptthemen laut MEDLINE: Psoriasis, Imiquimod, Vitamin K 3, Membrane Proteins. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cytosolic DNA sensing through the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) axis is an important component of innate host defense, whereas sustained pathway activation has been implicated in inflammatory and autoimmune diseases. Although several potent STING inhibitors are in preclinical development and ASP5502 has entered clinical evaluation, no STING inhibitor has received regulatory approval. Screening of an FDA-approved compound library identified vitamin K3 (VK3; menadione), a synthetic vitamin K analogue, as a compound that attenuated cellular responses elicited by SR717 and 2'3'-cGAMP. VK3 reduced IRF3 phosphorylation and the expression of interferon-related and inflammatory genes. In a cellular thermal shift assay (CETSA), VK3 did not produce detectable thermal stabilization of STING; therefore, its direct molecular target remains undefined. VK3 did not significantly reduce short-term THP-1 cell viability at the concentration used for signaling experiments. In LPS-challenged THP-1 cells, VK3 attenuated the induction of selected inflammatory transcripts, indicating that effects beyond STING-agonist-stimulated signaling cannot be excluded. In mice, topical VK3 attenuated imiquimod (IMQ)-induced psoriasis-like skin inflammation, reduced IL-17 and IL-23 expression, and did not appreciably affect body weight or the measured organ indices. Among the vitamin K analogues examined, VK3 showed the most consistent attenuation of STING-agonist-induced signaling. These findings support further investigation of VK3 as a topical modulator of inflammatory signaling in skin disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Gua…
- College of Life Sciences, Jilin Agricultural University, Changchun, Jilin 130118, China.
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Jin, Z., Huang, Z., Zhang, Y., Meng, M., Hong, L., & Li, M. (2026). Vitamin K3 attenuates STING-agonist-induced signaling and imiquimod-induced psoriasis-like inflammation. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118477
Vancouver
Jin Z, Huang Z, Zhang Y, Meng M, Hong L, Li M. Vitamin K3 attenuates STING-agonist-induced signaling and imiquimod-induced psoriasis-like inflammation. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118477
BibTeX
@article{Jin2026,
author = {Jin, Zuyi and Huang, Zhen and Zhang, Yiqin and Meng, Meichen and Hong, Liang and Li, Min},
title = {Vitamin K3 attenuates STING-agonist-induced signaling and imiquimod-induced psoriasis-like inflammation},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2026.118477}
}
EUVIMED